![](/img/cover-not-exists.png)
P-312 * A Phase 3 Open-Label, Randomized, Multicenter Study of Imprime PGG in Combination with Cetuximab in Patients with KRAS Wild Type Metastatic Colorectal Cancer
Huhn, R., Lowe, J., Grady, M., Taitt, C., Braun, A.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv233.309
Date:
June, 2015
File:
PDF, 30 KB
english, 2015